Atabak Mokari

CIK 1678419 · Chief Financial Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.43M

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$2.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT Chief Financial Officer 16,130 $82.91 $1.34M -$2.80M 20 2026-06-03
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Chief Financial Officer $0.07 $0 3 2020-04-09
IRIX CFO and VP Corp Development 81,967 $1.12 $91.8K $0 4 2018-12-13

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-04-09 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
2020-02-04 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
2018-12-20 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
2018-12-13 IRIX Tax (F) −6,013 -$738 EDGAR
2018-07-31 IRIX Grant (A) +16,800 $0 EDGAR
2017-07-26 IRIX Mixed +6,000 $57.2K EDGAR
2016-07-29 IRIX Grant (A) +65,000 $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.